Ginkgo Bioworks and Twist Bioscience Continue to Drive Industry Growth SAN FRANCISCO, Calif. and BOSTON, Mass. – Ginkgo Bioworks, the organism company, and Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA, today announced the expansion of a supply agreement for one billion base pairs of synthetic DNA – the […]

Assuring the highest accuracy in human identity testing for law enforcement and other uses Hilden, Germany, and Germantown, Maryland – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its manufacturing and supply chain for consumables and other products for forensic and human identity testing has been certified by Bureau Veritas, a leading inspection agency, as […]

San Carlos, California Today NuGEN Technologies announces a new line of indexing solutions designed to enable researchers to take full advantage of the latest generation of Illumina sequencers. The three new enhancements include the launch of 96 unique dual index pairs to address index hopping, the incorporation of molecular tags to accurately measure PCR duplication levels, and […]

MOUNTAIN VIEW, Calif. — Cellecta, Inc. today introduced CRISPRa (for activation) and CRISPRi (for inhibition) genome-wide, human and mouse pooled screening libraries to its extensive portfolio of CRISPR products and services. Cellecta also supplemented its current portfolio of CRISPR gene knockout libraries by adding a Mouse Genome-Wide CRISPR Knockout Library. These new additions to Cellecta’s CRISPR industry-leading, […]

Avacta appoints three business development executives in US including industry veteran as Vice President of Therapeutics Business Development Avacta is pleased to announce that it has established a commercial team of three people in the United States of America including the appointment of Dr Matthew Vincent as Vice President Therapeutics Business Development. In order to exploit the […]

Frameshift Genomics has recently been awarded two grants from the NHGRI, a phase I STTR and a phase I SBIR. In collaboration with the Marth Lab at the University of Utah, these grants aim to improve the IOBIO real-time genomic visualization and analysis project. Rapid and easy determination of genomic data quality problems is still challenging. Supported by one […]

ArcticZymes has today launched its SAN HQ ELISA immunoassay product which is targeted towards the bio-manufacturing market. ArcticZymes business has largely focused on serving the molecular biology and diagnostics markets. Serving the bio-manufacturing market is a new direction for ArcticZymes in its efforts to expand into other relevant segments. Through its unique products, ArcticZymes enter this market […]

AMSBIO announce the addition of mutation cell line Formalin-Fixed Paraffin-Embedded (FFPE) samples and isolated genomic DNA (gDNA) controls to its extensive range of cell line reference standards. In both routine clinical use and diagnostic assay development, biologically-relevant positive and negative controls represent an invaluable resource. To ensure accuracy and reproducibility during IVD assay development and […]